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Purpose: To determine which maintenance gas (sevoflurane versus desflurane) 
resulted in a faster emergence from general anesthesia and investigate the patient’s 
emergence agitation.  
Methods: One group was maintained during general anesthesia with sevoflurane 
and the other with desflurane. Upon emergence the patient’s behavior was evaluated. 
 vi 
vii 
Results: The average emergence time for desflurane was 9.8; while the average for 
sevoflurane was 13.98 minutes. Patients who received premedication had an emergence 
time of 15.43 minutes, while patients who received no premedication emerged after 8.34 
minutes. 
Zofran® was a significant predictor of purposeful actions. Patients were more 
aware of their surroundings when they received Zofran® compared to patients who did not 
receive Zofran®. 
Conclusion: Maintaining with desflurane and not premedicating patients allowed 
for a faster emergence from general anesthesia. Patients given Zofran® in their IV during 
the surgery had less emergence agitation then their counterparts.  
 
 
 
 
Introduction 
 
Early childhood caries is defined by the American Academy of Pediatric Dentistry 
(AAPD) as the presence of one or more decayed, missing, or filled (dmf) teeth in anyone 
under the age of 71 months.1 Dental caries is an infectious process that can start as soon as 
the first tooth erupts into the mouth and it can spread rapidly from one tooth to the next.  
Dental caries can lead to undesirable outcomes if left untreated that can affect all aspects of 
the child’s life.  The AAPD recognizes that there is a population of patients who cannot, 
for one reason or another, receive dental treatment using nonpharmacological techniques.1 
This population of patients, who because of their need for extensive treatment, acute 
situational anxiety, pre-cooperative or uncooperative age-appropriate behavior, immature 
cognitive functioning, disabilities, or medical conditions, it is more cost-effective, 
efficient, and humane to treat these children with general anesthesia.2    
 Induction for general anesthesia can be done via gases delivered by a facemask or 
medicine delivered intravenously (IV). Many of the pediatric patients undergoing general 
anesthesia will not tolerate the insertion of an IV while they are awake and alert. Therefore 
in the pediatric population, general anesthesia is often induced with gases (inhalants) 
delivered through a facemask.  
There are two aspects of general anesthesia that involve inhalants: the induction 
phase and the maintenance phase. The induction phase is defined as the time period when 
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the patient initially receives anesthetic medication until they become unconscious. The 
maintenance phase is defined as the period of time from intubation until the surgery is 
complete and the anesthetic gases have been turned off.  
Generally, sevoflurane is the inhalant used for induction because it is not a 
respiratory irritant and it has a less pungent odor. 3,4,12,14,15 It has been shown to be safe and 
highly efficacious.3 It has a rapid uptake and elimination because of its low blood-gas 
partial coefficient.3,4,14,15 Sevoflurane can be used as a maintenance gas as well, but due to 
its high cost, many anesthesiologists use other agents such as desflurane for the 
maintenance phase. 
 Desflurane is a relatively new gas that has been used in the maintenance phase but 
it has yet to be studied extensively in the pediatric population. Desflurane is not used to 
induce anesthesia because it is a respiratory irritant and it provokes complications like 
breath-holding and coughing, although there is no increase complications during 
maintenance and emergence.4,5 It has the lowest blood-gas and tissue-blood solubility 
coefficients of any inhaled anesthetic, which allows rapid uptake and elimination leading 
to a more rapid recovery with less lingering effects.5,12,14 These attributes make it a 
desirable anesthetic for the maintenance phase of general anesthesia. This is especially true 
in outpatient surgery centers where efficient patient management is crucial.  
 The emergence time from general anesthesia is defined as the end of the 
administration of anesthetic until extubation.6 This aspect of anesthesia is important 
because reducing time in the operating room and reducing the amount of time the 
anesthesiologist has in direct patient care reduces the staff costs which are the principal 
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aspect of any anesthesia cost regimen.6,8,13 It has been estimated that two-thirds of the total 
anesthetic expenditure is staff overhead.7 Faster emergence time reduces the time between 
cases and increases efficiency, which is an aspect of every cost effective plan.8 Economic 
awareness also has to consider patient satisfaction. One aspect of patient satisfaction is the 
behavior of the child post anesthesia.  
 A child’s emergence behavior from general anesthesia is important to both the 
health care provider and the parent. Often times, patients are agitated upon emergence and 
during the initial recovery period. Emergence agitation occurs most frequently during the 
initial 10 minutes of recovery and has been defined as non-purposeful restlessness, 
agitation, thrashing, crying or moaning, disorientation and incoherence.9,11,15  
There are limited studies that have examined the effectiveness of anesthetic 
protocols for reducing emergence agitation in children.  These studies have reported mixed 
results pertaining to the anesthetic gas used and patients’ emergence behavior. Cravero et 
al., reported sevoflurane as a maintenance inhalant produced agitation in 57% of patients 
while halothane produced agitation in 27% of patients.3 In a study by Valley et al, 
emergence agitation occurred in 45% of patients maintained by desflurane and 20% of 
patients maintained with sevoflurane.5 Ideally, levels of agitation and adverse events 
during the recovery period can be minimized with the appropriate selection of anesthetic 
gas.  
This study had two specific aims.  The first aim was to determine which 
maintenance gas resulted in a faster emergence from general anesthesia in the pediatric 
population. Since desflurane has the lowest blood-gas and tissue-blood solubility 
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coefficients of any inhaled anesthetic, we hypothesize that the children maintained with 
desflurane will emerge from anesthesia more quickly than those children maintained with 
sevoflurane.  The second aim was to determine if children undergoing general anesthesia 
displayed different emergence behavior when the anesthetic maintenance gas was 
sevoflurane versus desflurane. We hypothesized that children receiving desflurane as a 
maintenance inhalant would have less emergence agitation compared to patients receiving 
sevoflurane.  
 
 
 
  
Materials and Methods 
 
Study design 
 This was a prospective study of children receiving dental treatment under general 
anesthesia. Children were randomly assigned to receive one of two anesthetic gases for the 
maintenance phase of anesthesia. The first group was maintained during general anesthesia 
with sevoflurane (MAC 1-1.5). The second group was maintained during general 
anesthesia with desflurane (MAC 1-1.5). 
 
Patient Sample and Data Collection 
 The children enrolled in this study were patients whose caregivers had chosen 
general anesthesia for their child’s dental treatment at the Virginia Commonwealth 
University School of Dentistry, Department of Pediatric Dentistry.  The sample included 
55 children ages 4-15 with non-contributory medical histories who were randomly 
assigned to one of two anesthetic gases for the maintenance phase of anesthesia. Prior to 
their general anesthesia appointment, all children had a complete oral exam and a treatment 
plan was created. The children were also required to have a completed history and physical 
examination by a physician clearing the patients for general anesthesia within the previous 
30 days. All cases were completed on an outpatient basis in a dental office under the 
supervision of a dental anesthesiologist and a nurse anesthetist.  
 5 
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Anesthesia Protocol 
 The anesthesia protocol was the same for all cases except for the maintenance gas 
used during the surgery. The patients were induced with up to an 8% concentration of 
sevoflurane within 60% N2O and 40% O2. Once the airway was stable, an IV was placed 
and the patients were given 3-5 mcg/kg fentanyl, 1 mg/kg lidocaine, and up to 1-2 mg/kg 
propofol. Once the patient was intubated, the maintenance gas was turned on. The 
maintenance gas concentration of 3-5% was used to keep the patient anesthetized 
throughout the surgery. All maintenance inhalants were combined with 50% N2O and 50% 
O2.  Some patients were given Decadron® (Dexamethasone, Merck & Co., Inc.) and/or 
Zofran® (Ondansetron Hydrochloride, GlaxoSmithKline) for their antiemetic properties 
during the maintenance phase of anesthesia. Some patients were also given Toradol® 
(Ketorolac, Roche Laboratories) for analgesia post operatively. The patient’s blood 
pressure, heart rate, hemoglobin oxygen saturation and end tidal CO2 were monitored 
throughout the procedure and documented at five-minute intervals until the patients were 
responsive and recovery completed. Upon completion of the dental treatment and removal 
of the throat pack, the anesthetic maintenance gas was turned off and the patients were 
given 100% oxygen. The patients were extubated once they were breathing spontaneously 
and had one of the following signs: eye opening or purposeful movements.   
 
PAED Scale 
 Upon emergence the patient’s behavior was evaluated using the validated Pediatric 
Anesthesia Emergence Delirium Scale (PAED).4,9 An evaluator blinded to the maintenance 
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anesthetic gas completed evaluations at 5-minute intervals for 30 minutes beginning 
immediately upon extubation. It was the responsibility of the dentist performing the dental 
surgery to be the evaluator. Each evaluator was trained and calibrated in using the PAED 
instrument.  
 As Table 1 shows, the PAED Scale has five items: The first three are: (EC) The 
child makes eye contact with the caregiver, (PA) The child’s actions are purposeful, and 
(AS) The child is aware of his/her surroundings. These items are scored: 4 = not at all, 3 = 
just a little, 2 = quite a bit, 1 = very much, 0 = extremely. The last two items are: (R) The 
child is restless, and (I) The child is inconsolable. These items are scored: 0 = not at all, 1 
= just a little, 2 = quite a bit, 3 = very much, or 4 = extremely. Note that more desirable 
behavior/less delirium has lower scores while less desirable behaviors/ increased delirium 
have higher scores.  
 
Control Variables 
 The following control variables were recorded: age, race, gender, weight, ASA 
(American Society of Anesthesiology) status, length of treatment, procedures completed, 
local anesthetic administered, drugs administered during anesthesia, medical history, 
administration of premedication, and extubation time.  
 
Human Subjects 
 This study was conducted in compliance with the standard of care set forth by the 
American Academy of Pediatric Dentistry, the American Society of Anesthesiologist, and 
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the American Association of Nurse Anesthetists. The Virginia Commonwealth University 
Institutional Review Board approved this study for human subjects.  All parents gave their 
written informed consent for their children to participate in the investigation.  
 
Statistical Analysis 
 The independent variable in this study was the anesthetic gas (sevoflurane versus 
desflurane) used for the maintenance of general anesthesia.  The principal outcome was the 
patient’s PAED score across the emergence/recovery time period.  Descriptive statistics 
were completed for patient characteristics such as gender, ASA status, the use of 
premedication, extractions performed, local anesthetic received, maintenance gas, age, 
weight, and length of procedure.  Depending on the anesthesia provider, patients were 
given Decadron® for its anti-inflammatory and antiemetic properties, Zofran® for its 
antiemetic properties, and Toradol® for postoperative analgesia. Comparisons at baseline 
were performed using multi-way ANOVA and comparisons across time were done using a 
repeated-measures mixed-model that accounted for the within-subject correlation across 
time. All tests were done at the Alpha = .05 level of significance using SAS software.10
  
  
Results 
 
 The final study sample consisted of 55 subjects. As seen in Table 2, approximately 
half of the sampled patients were female and half were male. Patients ranged in age from 3 
years and 1month to15 years and 11 months; with a median age of 6 years and 5 months. 
Subjects’ weight’s ranged from 15-61(kg) with a median of 23(kg). The majority of the 
patients (85%) were ASA class I, and over half of the patients (62%) received 
premedication prior to the induction of anesthesia. About 75% of the patients had 
extractions and therefore received local anesthesia. Treatment time varied between 45 
minutes to 4 hours and 41 minutes with a median treatment time of 1 hour and 42 minutes. 
The distribution of the maintenance gas for the sample was 51% sevoflurane and 49% 
desflurane. 
 Medications that were administered during the procedures for pain and/or nausea 
have been summarized in Table 3. Three medications (Decadron®, Zofran®, Toradol®) 
were given to 65% of patients. 9% of the patients received Zofran® and Toradol®, while 
7% received Decadron® alone. The combination of Decadron® and Toradol® was used by 
2% and the combination of Decadron® and Zofran® by 16% of the patients.  
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Emergence Time  
 Overall, the mean emergence time was 14.14 minutes. The average emergence time 
for desflurane was 9.8 minutes (2.36); while the average for sevoflurane was 13.98 
minutes (2.41). Patients who were given premedication had an emergence time of 15.43 
minutes, while patients who were not given premedication had an emergence time of 8.34 
minutes. The length of emergence in minutes was analyzed using multi-way ANOVA.  
There was a statistical difference in emergence time due to both the maintenance 
gas (p = 0.024) and the use of premedication (p = 0.001). The average emergence time was 
4.17 minutes longer with sevoflurane then desflurane (95% CI = 0.57-7.78). Emergence 
time was also 7.09 minutes longer when premedication was used (95% CI = 3.30-10.88).  
There was no difference in emergence time due to the use of a local anesthetic (p > 0.5) or 
pain/nausea medications Decadron® (p > 0.8), Zofran® (p > 0.6), or Toradol® (p > 0.2). 
These results are summarized in Table 4 and Figures 1-2. 
 
Pediatric Anesthesia Emergence Delirium (PAED) Scale 
 Tables 5 and 6 summarize the mean PAED scale results across time. Generally, EC 
begins at “just a little” and by 30 minutes is at “very much”. PA begins between “quite a 
bit” and “just a little” and by 30 minutes is at “very much”. AS begins between “just a 
little” and “not at all” and by 30 minutes is “very much”. Restlessness and inconsolable is 
low overall, beginning at “just a little” and ending at “not at all”. The trend showed that 
patient’s agitation improved over the thirty minute time period. 
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 To determine which anesthesia factors were significantly related to emergence 
behavior over time, a multi-way ANOVA was used.  At extubation (time 0), PAED values 
and the following two-level factors were considered: premedication, local anesthetic, 
Decadron®, Zofran®, Toradol®, and maintenance gas. Table 7 summarizes the p-values 
for the multi-way ANOVAs indicating that only the use of Zofran® was a significant 
predictor of purposeful actions (PA p-value = 0.04). 
 Since Zofran® use appeared to impact emergence behavior at time 0, it was 
included in the repeated-measures mixed-model analysis of PAED behavior across the 7 
time points (that is, from 0 up to 30 minutes in 5 minute increments).  The following 
factors were included: maintenance gas, Zofran® use, time, time*gas, and 
time*gas*Zofran® (SAS Institute, version 9.1, Proc Mixed unstructured covariance 
matrix). The time*gas interaction effect was the test of interest. It indicated that the time 
trend is different in the two gas groups. Additionally, the three-way interaction tested 
whether the different time trend in the two gas groups is affected by Zofran® use. The 
results of the repeated-measures ANOVAs are shown in Table 8.   
 Eye contact (EC) improved across time (p < .0001) and did not vary depending 
upon gas or Zofran® use. The predicted mean EC score at each time point have been 
plotted in Table 9 and Figure 3. Purposeful actions (PA) improved across time (p < .0001) 
and did not vary depending upon gas (ps > 0.8). The predicted mean score for PA at each 
time point have been plotted in Table 10 and Figure 4.  Note that there is a difference in 
purposeful actions due to Zofran® use (p = 0.0103). As seen in Figure 5, without Zofran® 
the purposeful action began at about 3.67 in both gas groups and improved to 
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approximately 1.5. With Zofran® the purposeful actions began at approximately 2.5 and 
improved to 0.83. Therefore, patients had more purposeful actions when they were given 
Zofran® in their IV. Awareness of surroundings (AS) improved across time as shown in 
Table 11 and Figure 6 (p < .0001) and did vary depending upon gas and Zofran® use as 
shown in Figure 7 (p-value < 0.05). Patients were more aware of their surroundings when 
they received Zofran® compared to patients who did not receive Zofran®.  Patients who 
received Zofran® and desflurane were more aware of their surroundings then the patients 
who received Zofran® and sevoflurane. Because of the relationship with Zofran® use, it is 
more appropriate to inspect the relationship with a three-way interaction. (p-value = 
0.0091).  The predicted mean AS score at each time point for the three-way interaction of 
gas*time*Zofran® have been plotted in Figure 7.  In patients who were not given 
Zofran®, there was no gas difference. In patients who were given Zofran®, there is a 
difference in emergence agitation between the two maintenance gas groups.   
 Restlessness (R) did not change over time and did not vary depending upon gas or 
Zofran® use. The predicted mean R score at each time point for each maintenance gas is 
shown in Table 12 and Figure 8.  Also, inconsolability (I) did not change over time and did 
not vary depending upon gas or Zofran® use. The predicted mean I score for each 
maintenance gas over time is shown in Table 13 and Figure 9.  
  
  
Discussion 
 
In this study, desflurane as a maintenance inhalant allowed for a quicker emergence 
time from general anesthesia when compared to sevoflurane. This is due to the fact that 
desflurane has the lowest blood-gas and tissue-blood coefficient of any anesthetic 
inhalant.5,12,14 From a case efficiency standpoint, knowing that desflurane produced a faster 
emergence time may be beneficial. The shorter the emergence time, the faster the room can 
be turned over and patient waiting time can be reduced.  
Premedication is often used for the purpose of not upsetting the child upon 
separation from their caregiver and a smoother induction of anesthesia. This study found 
the use of premedication in patients lead to a longer emergence time, but did not seem to 
affect their emergence delirium/behaviors at the end of the case. This coincides with a 
study by Valley et al, which found the incidence of emergence agitation did not differ with 
midazolam premedication.5 Local anesthetic, Decadron®, Toradol®, and Zofran® are 
used during anesthesia to reduce nausea and pain experienced by the patient during 
recovery. These medications were used according to the recommended dosages per weight. 
The use of Decadron® and Toradol® did not affect the patient’s emergence time in this 
study.  
As expected, the patient’s delirium score as measured by the Pediatric Anesthesia 
Emergence Delirium instrument (PAED) were “more delirious” at the point of extubation 
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and became “less delirious” over the 30-minute time period. Similar to other studies, the 
patient’s emergence agitation subsided after the initial 10 minutes11.  
We found that there were no differences in emergence behavior when examining 
the maintenance inhalant used for the case. Neither desflurane nor sevoflurane alone 
produced more or less agitation upon emergence. We believe that anesthesia providers can 
base their choice of maintenance inhalant agent using other factors besides emergence 
delirium.  
We then examined the impact of other drugs used during anesthesia on emergence 
delirium. We found that neither Toradol®, Decadron®, nor local anesthetic seemed to 
affect the patients PAED scores. Toradol® is an analgesic and expected to reduce the level 
of pain the patient experiences and therefore reduce their agitation.  There were no 
statistical differences in PAED scores for patients who received Toradol® versus those that 
did not. Decadron® is a steroid that is used for its anti-inflammatory and antiemetic 
properties. The use of Decadron® did not affect the patient’s PAED scores. Local 
anesthetic may sometimes agitate patients if they are too young to understand the concept 
of “facial numbness”. Again, there was not a difference in PAED scores for patients with 
and without local anesthesia.  These medications have a useful impact on the patient during 
general anesthesia, but they did not affect their emergence agitation or their PAED scores.  
We found that Zofran® had a significant affect on the patients’ emergence 
behavior. Zofran® reduced emergence agitation by enabling the patients to be more aware 
of their surroundings and have more purposeful actions. When Zofran® was used, patients 
maintained with desflurane were even more aware of their surroundings upon emergence 
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compared to those maintained with sevoflurane. Therefore, Zofran® is beneficial from the 
patient’s perspective, as they are less agitated upon emergence. Neither the maintenance 
gas nor the various medications used during the study affected the patient’s eye contact, 
consolability, and restlessness during the thirty minutes of recovery. All three measures 
improved over time and were not altered by any medication. 
 
Limitations 
Many additional factors can affect a patient’s emergence behavior including, but not 
limited to, fear of pain, type of patients seen in a pediatric dental residency, the procedure 
performed upon them, and even personality characteristics. Experiencing pain may be a 
significant factor in the manifestation of emergence agitation especially in the pediatric 
population. If the patient is not mature enough to verbalize their discomfort their behavior 
may be misinterpreted as emergence delirium. A patient’s anxiety and reaction to being in 
an unfamiliar environment, the presence of strangers, or separation from their parents or 
caregivers may also be misconstrued as emergence agitation. According to Pryzbylo et al, 
agitation is increased due to sensory deprivation.16 Sensory deprivation is unavoidable in a 
general anesthesia setting and may have impacted the results. 
The classification of a patient’s behavior according to the PAED scale is subjective. 
Having multiple evaluators may have affected the results due to the subjectivity inherent in 
the scale even though all evaluators were calibrated prior to data collection.  Different 
anesthesia providers may have affected the results even though the protocol was the same 
for all patients. Some anesthesia personnel prefer to have the patient breathing on their 
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own, while others prefer to override the patient’s breathing mechanism and use the 
ventilator. This may have affected how much gas the patient received and impact of the 
anesthesia for the individual patient physiologically.  
This study shows that the use of desflurane as a maintenance inhalant is beneficial 
due to its rapid emergence time compared to sevoflurane. It is also interesting to note that 
the use of premedication produced a slower emergence from general anesthesia. This is 
beneficial for anesthesia providers who are interested in improving the turn over time of 
their caseload. The use of Zofran® during the case helped to reduce the patient’s 
emergence agitation. This is beneficial for the recovery staff and parents. It is difficult for 
the parents to watch their child experience severe agitation. Anything that can be done to 
reduce this agitation is valuable. 
Future studies that focus on reducing pediatric patient’s emergence delirium are 
needed. It was interesting to see that Zofran® had such an impact on the patient’s PAED 
scores. Further investigation by designing a study that used Zofran® as its independent 
variable with a standardized anesthesia protocol may be beneficial.
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Table 1: Pediatric Anesthesia Emergence Delirium (PAED) Scale9
Pediatric Anesthesia Emergence Delirium (PAED) Scale 
1. The child makes eye contact with the caregiver 
2. The child’s actions are purposeful  
3. The child is aware of his/her surroundings 
4 = not at all 
3 = just a little 
2 = quite a bit 
1 = very much  
0 = extremely 
1. The child is restless 
2. The child is inconsolable 
0 = not at all 
1 = just a little 
2 = quite a bit 
3 = very much  
4 = extremely 
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Table 2: Description of Patients 
Characteristic N Percent
Gender
Female 26 47
Male 29 53
ASA
I 47
II 8 15
Premedication
No 21 38
Yes 34 62
Extractions
No 13 24
Yes 42 76
Local anesthetic
No 12 22
Yes 43 78
Maintenance Gas
Desflurane 27 49
Sevoflurane 28 51
Mean SD
Age (years) 7.40 3.28
Weight (KG) 27.36 12.33
Length of TX (hours) 1.95 0.97
85
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Table 3: Medications Administered During General Anesthesia 
 
Medication N Percent
Decadron®
No 5 9
Yes 50 91
Zofran®
No 5 9
Yes 50 91
Torodol®
No 13 24
Yes 42 76
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Table 4: Emergence Time 
 
Groups n LS Mean SE
Maintenance gas
Desflurane 27 9.80 2.36 5.06 14.54
Sevoflurane 28 13.98 2.41 9.14 18.81
difference 4.17 1.79 0.57 7.78
Premedication
No 21 8.34 2.61 3.09 13.59
Yes 34 15.43 2.17 11.07 19.80
difference 7.09 1.89 3.30 10.88
95% CI
Emergence Time (minutes)
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Table 5: PAED scale results at each time point  
 
 
Time
0= 
extremely
1= very 
much
2=quite a 
bit
3=just a 
little
4=not at 
all Mean SD
0 3 4 3 18 25 3.09 1
5 8 5 6 16 20 2.64 1
10 11 11 11 15 7 1.93 1.35
15 18 9 11 12 5 1.58 1.38
20 22 12 10 8 3 1.24 1.28
25 25 13 12 3 2 0.98 1.11
30 30 14 7 2 2 0.76 1
0 4 5 14 15 15 2.60 1.21
5 7 7 12 17 12 2.36 1.31
10 12 10 16 7 10 1.87 1.39
15 15 13 11 8 8 1.65 1.40
20 21 12 7 10 5 1.38 1.39
25 24 15 8 4 4 1.07 1
30 28 15 5 3 4 0.91 1
0 1 0 1 17 34 3.57 0
5 2 5 9 18 21 2.93 1
10 8 7 15 13 12 2.25 1.34
15 13 13 12 7 10 1.78 1.42
20 21 16 8 6 4 1.20 1
25 23 19 7 3 3 0.98 1
30 29 16 5 3 2 0.78 1
Time
0=not at 
all
1=just a 
little
2=quite a 
bit
3=very 
much
4= 
extremely Mean SD
0 21 15 8 6 3 1.15 1
5 26 14 8 7 0 0.93 1
10 29 13 9 4 0 0.78 0
15 33 15 7 0 0 0.53 0
20 39 11 5 0 0 0.38 0
25 38 14 3 0 0 0.36 0
30 41 10 2 2 0 0.36 0
0 32 10 3 6 2 0.79 1
5 30 16 4 4 1 0.73 1
10 34 10 5 6 0 0.69 1
15 37 13 4 1 0 0.44 0
20 40 10 4 1 0 0.38 0
25 41 10 3 1 0 0.35 0
30 43 10 2 0 0 0.25 0
I: The child is inconsolable
EC: The child makes eye contact with the caregive
.16
.43
.05
.25
.22
.72
.12
.27
.13
.07
.23
.07
.98
.72
.65
.59
.73
.20
.01
.03
.71
.71
.67
.52
r
PA: The child's actions are purposeful
AS: The child is aware of his/her surroundings
R: The child is restless
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Table 6: PAED results at baseline and 30 minutes 
 
 
Time
0= 
extremely
1=very 
much
2=quite a 
bit
3=just a 
little
4=not at 
all Mean SD
0 3 4 3 18 25 3.09 1
30 30 14 7 2 2 0.76 1
0 4 5 14 15 15 2.60 1.21
30 28 15 5 3 4 0.91 1
0 1 0 1 17 34 3.57 0
30 29 16 5 3 2 0.78 1
Time
0=not at 
all
1=just a 
little
2=quite a 
bit
3=very 
much
4= 
extremely Mean SD
0 21 15 8 6 3 1.15 1
30 41 10 2 2 0 0.36 0
0 32 10 3 6 2 0.79 1
30 43 10 2 0 0 0.25 0
PA: The child's actions are purposeful
AS: The child is aware of his/her surroundings
E: Eye Contact
R: The child is restless
I: The child is inconsolable
.16
.05
.22
.72
.07
.23
.73
.20
.52
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Table 7: P-values for Multiway ANOVAs of the Baseline PAED  
 
Effect EC PA AS R I
PreMed (YN) 0.3671 0.4700 0.2720 0.9888 0.3933
Local (YN) 0.9580 0.5750 0.8474 0.8608 0.0639
Decadron® (YN) 0.4354 0.7026 0.8627 0.1411 0.0644
Zofran® (YN) 0.2776 0.0413 0.2257 0.1231 0.2249
Torodol® (YN) 0.8554 0.2314 0.4882 0.9472 0.5073
Gas 0.1550 0.8836 0.2970 0.2821 0.2334
PAED scale
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Table 8: Repeated-measures ANOVA of PAED scales  
 
Effect df EC PA AS R I
Gas 1 0.9483 0.9446 0.6910 0.9812 0.9317
Zofran® 1 0.1484 0.0103 0.0451 0.1336 0.1149
Time 6 <.0001 <.0001 <.0001 0.5106 0.4378
Gas*Time 6 0.6111 0.9032 0.0015 0.3047 0.7415
Gas*Zofran®*Time 13 0.8354 0.8460 0.0091 0.6017 0.7081
PAED scale
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Table 9: Eye Contact LS Means  
 
Time Desflurane Sevoflurane
0 3.49 3.35
5 2.75 3.31
10 2.38 1.98
15 2.04 1.56
20 1.65 1.65
25 1.19 1.31
30 0.81 0.92
Maintenance Gas
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Table 10: Purposeful Actions LS Means 
 
Time Desflurane Sevoflurane
0 2.98 3.21
5 2.85 3.19
10 2.42 2.48
15 2.19 2.10
20 2.02 1.96
25 1.54 1.58
30 1.31 1.02
Maintenance Gas
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Table 11: Awareness of Surroundings LS Means 
 
Time Desflurane Sevoflurane
0 3.84 3.70
5 3.23 3.58
10 2.58 2.96
15 2.02 2.02
20 1.69 1.58
25 0.90 1.54
30 1.10 1.17
Maintenance Gas
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Table 12: Restlessness LS Means 
 
Time Desflurane Sevoflurane
0 0.92 0.54
5 0.50 0.52
10 0.60 0.87
15 0.27 0.54
20 0.27 0.38
25 0.40 0.38
30 0.44 0.12
Maintenance Gas
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Table 13: Inconsolability LS Means 
 
Time Desflurane Sevoflurane
0 0.64 0.33
5 0.46 0.35
10 0.42 0.81
15 0.25 0.46
20 0.29 0.37
25 0.25 0.13
30 0.13 0.15
Maintenance Gas
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Figure 1: Emergence Time Difference for Maintenance Gas  
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Figure 2: Emergence Time Difference for Premedication (Yes/No)  
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Figure 3: Eye Contact Across Time for the Maintenance Gas Groups  
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Figures 4: Purposeful Action Across Time for the Maintenance Gas Groups  
37 
 
0
1
2
3
4
0 5 10 15 20 25 30
Time (hours)
PA
ED
: P
ur
po
se
fu
l A
ct
io
ns
Desflurane, No Zofran®
Desflurane, Zofran®
Sevoflurane, No Zofran®
Sevoflurane, Zofran®
 
Figure 5: Purposeful Action with Maintenance Gas and Zofran® Use  
38 
 
0
1
2
3
4
0 5 10 15 20 25 30
Time (hours)
PA
ED
: A
w
ar
e 
of
 S
ur
ro
un
di
ng
s
Desflurane
Sevoflurane
 
Figure 6: Awareness of Surroundings Across Time for the Maintenance Gas Groups 
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Figure 7: Awareness of Surroundings with Maintenance Gas and Zofran® Use 
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Figure 8: Restlessness Across Time for the Maintenance Gas Groups 
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Figure 9: Inconsolability Across Time for the Maintenance Gas Groups 
 
 
 
 
 
 
 
 
 
42 
 
VITA 
 
Carla J. LaLande was born April 25, 1979 in Omaha, NE. She graduated from Lake 
Havasu High School in 1997. She graduated Magna Cum Laude from the University of 
Nevada, Las Vegas in 2001 receiving a BA in Criminal Justice with minors in Biology and 
Chemistry. Dr. LaLande graduated Summa Cum Laude from the University of Nevada, 
Las Vegas, School of Dental Medicine in 2006. She was the recipient of the William S. 
Cramer Award of Excellence as a member of Omicron Kappa Upsilon.  
  
